Copyright
©The Author(s) 2015.
World J Cardiol. Oct 26, 2015; 7(10): 594-602
Published online Oct 26, 2015. doi: 10.4330/wjc.v7.i10.594
Published online Oct 26, 2015. doi: 10.4330/wjc.v7.i10.594
Figure 1 General architecture of the bare metal stent (A) and drug eluting stents (B) sequential model.
DES: Drug eluting stents; BMS: Bare metal stent; PCI: Percutaneous coronary interventions; CABG: Coronary artery bypass graft; CBA: Coronary balloon angioplasty.
Figure 2 Cost distribution shape of the bare metal stent strategy (X axis: % success rate; Y axis: Occurrence probability).
Figure 3 Cost distribution shape of the drug eluting stents strategy (X axis: % success rate; Y axis: Occurrence probability).
- Citation: Beresniak A, Caruba T, Sabatier B, Juillière Y, Dubourg O, Danchin N. Cost-effectiveness modelling of percutaneous coronary interventions in stable coronary artery disease. World J Cardiol 2015; 7(10): 594-602
- URL: https://www.wjgnet.com/1949-8462/full/v7/i10/594.htm
- DOI: https://dx.doi.org/10.4330/wjc.v7.i10.594